Heart Test Laboratories (NASDAQ:HSCS) Shares Down 1.5% – Here’s Why

Heart Test Laboratories, Inc. (NASDAQ:HSCS)’s stock price was down 1.5% during mid-day trading on Friday . The company traded as low as $2.57 and last traded at $2.59. Approximately 17,903 shares traded hands during trading, a decline of 87% from the average daily volume of 140,511 shares. The stock had previously closed at $2.63.

Analyst Upgrades and Downgrades

Separately, Ascendiant Capital Markets restated a “buy” rating and issued a $15.00 price target on shares of Heart Test Laboratories in a report on Monday, September 23rd.

Heart Test Laboratories Price Performance

The company has a debt-to-equity ratio of 0.08, a quick ratio of 4.02 and a current ratio of 4.49. The firm has a market cap of $2.36 million, a price-to-earnings ratio of -0.12 and a beta of 3.27. The company’s fifty day moving average is $3.40 and its two-hundred day moving average is $4.47.

Heart Test Laboratories (NASDAQ:HSCS) last released its quarterly earnings data on Thursday, September 12th. The company reported ($2.64) EPS for the quarter. Equities research analysts forecast that Heart Test Laboratories, Inc. will post -9.82 EPS for the current year.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.